Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
07 2019
Historique:
received: 30 08 2018
revised: 12 10 2018
accepted: 22 10 2018
pubmed: 14 11 2018
medline: 12 5 2020
entrez: 14 11 2018
Statut: ppublish

Résumé

We report results from the second annual screening round (T1) of Manchester's 'Lung Health Check' pilot of community-based lung cancer screening in deprived areas (undertaken June to August 2017). Screening adherence was 90% (n=1194/1323): 92% of CT scans were classified negative, 6% indeterminate and 2.5% positive; there were no interval cancers. Lung cancer incidence was 1.6% (n=19), 79% stage I, treatments included surgery (42%, n=9), stereotactic ablative radiotherapy (26%, n=5) and radical radiotherapy (5%, n=1). False-positive rate was 34.5% (n=10/29), representing 0.8% of T1 participants (n=10/1194). Targeted community-based lung cancer screening promotes high screening adherence and detects high rates of early stage lung cancer.

Identifiants

pubmed: 30420406
pii: thoraxjnl-2018-212547
doi: 10.1136/thoraxjnl-2018-212547
pmc: PMC6585285
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

700-704

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):4-9
pubmed: 19262443
Am J Respir Crit Care Med. 2009 Sep 1;180(5):445-53
pubmed: 19520905
N Engl J Med. 2009 Dec 3;361(23):2221-9
pubmed: 19955524
BMJ. 2011 Apr 27;342:d2110
pubmed: 21525094
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Eur J Cancer Prev. 2012 May;21(3):308-15
pubmed: 22465911
N Engl J Med. 2013 Feb 21;368(8):728-36
pubmed: 23425165
J Thorac Oncol. 2013 Jul;8(7):866-75
pubmed: 23612465
Thorax. 2015 Aug;70 Suppl 2:ii1-ii54
pubmed: 26082159
Thorax. 2019 Apr;74(4):405-409
pubmed: 29440588

Auteurs

Phil A Crosbie (PA)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Haval Balata (H)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Matthew Evison (M)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Melanie Atack (M)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Val Bayliss-Brideaux (V)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Denis Colligan (D)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.
Manchester Health and Care Commissioning, Manchester, UK.

Rebecca Duerden (R)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Josephine Eaglesfield (J)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Timothy Edwards (T)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Peter Elton (P)

Greater Manchester, Lancashire, South Cumbria Strategic Clinical Network, Manchester, UK.

Julie Foster (J)

Manchester City Council, Manchester, UK.

Melanie Greaves (M)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Graham Hayler (G)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Coral Higgins (C)

Manchester Health and Care Commissioning, Manchester, UK.

John Howells (J)

Department of Radiology, Royal Preston Hospital, Preston, UK.

Klaus Irion (K)

Department of Radiology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.

Devinda Karunaratne (D)

Department of Radiology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.

Jodie Kelly (J)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Zoe King (Z)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Judith Lyons (J)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Sarah Manson (S)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Stuart Mellor (S)

Department of Radiology, Royal Blackburn Hospital, Blackburn, UK.

Donna Miller (D)

The Black Health Agency, Manchester, UK.

Amanda Myerscough (A)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Tom Newton (T)

Department of Radiology, Royal Blackburn Hospital, Blackburn, UK.

Michelle O'Leary (M)

Macmillan Cancer Support, Manchester, UK.

Rachel Pearson (R)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.
Manchester Health and Care Commissioning, Manchester, UK.

Julie Pickford (J)

Manchester City Council, Manchester, UK.

Richard Sawyer (R)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Nick J Screaton (NJ)

Department of Radiology, Papworth Hospital, Cambridge, UK.

Anna Sharman (A)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Maggi Simmons (M)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Elaine Smith (E)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Ben Taylor (B)

Department of Radiology, Christie NHS Foundation Trust, Manchester, UK.

Sarah Taylor (S)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.
Manchester Health and Care Commissioning, Manchester, UK.

Anna Walsham (A)

Department of Radiology, Salford Royal NHS Foundation Trust, Salford, UK.

Angela Watts (A)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

James Whittaker (J)

Department of Radiology, Stockport NHS Foundation Trust, Stockport, UK.

Laura Yarnell (L)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.
Manchester Health and Care Commissioning, Manchester, UK.

Anthony Threlfall (A)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.

Phil V Barber (PV)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Janet Tonge (J)

Manchester Clinical Commissioning Group, Macmillan Cancer Improvement Partnership, Manchester, UK.
Manchester Health and Care Commissioning, Manchester, UK.

Richard Booton (R)

Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH